The said vaccine is now being developed in various laboratories worldwide from clinical testing. The report was recently announced in the Proceedings of the National Academy of Sciences which tells that such vaccines, once fully tested, will effectively weaken the flu virus, without affecting its adaptable components that allow it to become immune to current treatment.
"Because the flu quickly evolves to escape host immunity, current vaccines tend to be prioritized for inoculating specific high-risk groups such as asthma sufferers and the elderly every year," says Nimalan Arinaminpathy, the postdoctoral research associate for the study in Princeton.
"So, at the moment, vaccine programs focus on clinical protection for those receiving the vaccine, but we hope to eventually graduate to being able to control the virus' spread and even its evolution," he said. "Our model provides a strong conceptual basis as to how and why the 'universal' vaccines would achieve that."
Is this the start of the end in our prevention and cure for flu? We'll have to wait for a few more years to see.